Dual Prognostic Significance of P2RY12 in Antithrombotic-Treated STEMI – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Jiqing Li et al, published in Journal of Thrombosis and Haemostasis, adding:
“The dual role of P2RY12: Impact of polymorphism and expression on ischemic events and bleeding in patients with ST-segment elevation myocardial infarction receiving antithrombotic therapy.
In 1828 STEMI patients on ticagrelor, P2RY12 polymorphisms and expression levels showed opposing effects on ischemic and bleeding risks, revealing novel nonlinear relationships for refined cardiovascular risk stratification.”
Title: The dual role of P2RY12: impact of polymorphism and expression on ischemic events and bleeding in patients with ST-segment elevation myocardial infarction receiving antithrombotic therapy
Authors: Jiqing Li, Zheng Gong, Shikun Wang, Jianhua Gu, Shuo Wu, Jiaojiao Pang, Yuguo Chen
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 20, 2026, 16:51Suzan Nakasendwa: A Growing Stroke Challenge in Uganda
-
Oct 20, 2026, 16:38Steve Moon: How Does Smoking Cessation Duration Affect Ischemic Stroke Risk
-
Oct 20, 2026, 16:25Cedrice Mentor: Reducing Platelet Wastage Through Cold Storage
-
Oct 20, 2026, 16:09Thirunavukkarasu Angappan: Can a Purified Fibrinogen Concentrate Replace Cryoprecipitate
-
Oct 20, 2026, 16:01Kalyan Roy: Platelet Conservation Through Evidence-Based Transfusion Practice
-
Oct 20, 2026, 15:28Stacy E. Croteau: 33 Countries, One Mission – Better Bleeding Disorder Care
-
Oct 20, 2026, 15:19Teresa Barnes: What Does a Pulmonary Embolism Mean for Jalen Hurts?
-
Oct 20, 2026, 15:04Laura S.: Could Speaking Up Prevent Maternal Deaths from Thrombosis?
-
Oct 20, 2026, 14:44Pete Stibbs: VTE in Professional Athletes – When Fitness Is Not Enough